Post Marketing Surveillance Study for MenQuadfi® [Meningococcal (Groups A, C, Y, W) Polysaccharide Tetanus Toxoid Conjugate Vaccine] Administered in Participants Aged 6 Weeks to 55 Years in Republic of Korea
Clinical trial NCT07621653 · RECRUITING
Trial details
- NCT number
- NCT07621653
- Sponsor
- Sanofi
- Status
- RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-07-01
- Primary completion
- 2027-11-23
- Enrollment
- 706
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.